title: Interleukin-1 represses COLIA1 promoter activity in calvarial bones of transgenic ColCAT mice in vitro and in vivo.
abstract: Interleukin-1 (IL-1) inhibits collagen synthesis in osteoblastic cell lines and primary osteoblast-like cells. However, promoter elements regulating type I collagen A1 (COLIA1) expression in vivo and in organ culture may differ from those regulating expression in cell culture. We have examined the effects of IL-1 on reporter gene activity in neonatal transgenic mouse calvariae bearing COLIA1 promoter-chloramphenicol acetyltransferase (ColCAT) fusion genes. The parent construct, ColCAT 3.6, contains 3.5 kb of 5' flanking sequence and 115 bp of 5' untranslated region fused to the CAT reporter. In 48-h calvarial organ cultures, IL-1 repressed ColCAT 3.6 promoter activity and collagen synthesis in a dose-related manner, with a maximal inhibition of 40-65%. This repression was retained in 5' deletion constructs truncated to-1719 bp. The inhibition of transgene mRNA was blocked by cycloheximide, indicating a requirement for new protein synthesis. Pretreatment with indomethacin diminished the inhibitory effect of IL-1 on CAT activity and collagen synthesis, suggesting partial mediation by prostaglandins. Local in vivo injection of IL-1 (500 ng) decreased calvarial transgene mRNA after 8 h, an effect that was partially blocked by indomethacin. ColCAT transgenic mice represent a useful model for in vitro and in vivo assessment of COLIA promoter regulation by cytokines and other factors.
authors.affiliation: Department of Medicine, University of Connecticut Health Center, Farmington, USA.
authors.forename: J R
authors.initials: JR
authors.lastname: Harrison
authors.forename: L M
authors.initials: LM
authors.lastname: Kleinert
authors.forename: P L
authors.initials: PL
authors.lastname: Kelly
authors.forename: P H
authors.initials: PH
authors.lastname: Krebsbach
authors.forename: C
authors.initials: C
authors.lastname: Woody
authors.forename: S
authors.initials: S
authors.lastname: Clark
authors.forename: D W
authors.initials: DW
authors.lastname: Rowe
authors.forename: A C
authors.initials: AC
authors.lastname: Lichtler
authors.forename: B E
authors.initials: BE
authors.lastname: Kream
mesh_terms: D000818:Animals; D015500:Chloramphenicol O-Acetyltransferase / Q000037:antagonists & inhibitors / Q000235:genetics*; D003094:Collagen / Q000037:antagonists & inhibitors / Q000235:genetics*; D003513:Cycloheximide / Q000494:pharmacology; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects; D017930:Genes, Reporter / Q000187:drug effects; D007213:Indomethacin / Q000494:pharmacology; D007375:Interleukin-1 / Q000494:pharmacology*; D051379:Mice; D008822:Mice, Transgenic; D009924:Organ Culture Techniques; D011401:Promoter Regions, Genetic / Q000187:drug effects*; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D012333:RNA, Messenger / Q000037:antagonists & inhibitors; D012886:Skull / Q000187:drug effects* / Q000378:metabolism
chemical_list: D016861:Cyclooxygenase Inhibitors; D007375:Interleukin-1; D011500:Protein Synthesis Inhibitors; D012333:RNA, Messenger; D003094:Collagen; D003513:Cycloheximide; D015500:Chloramphenicol O-Acetyltransferase; D007213:Indomethacin